alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATION  PURSUANT  TO  SECTION  302  OF  THE  SARBANES-OXLEY  ACT  OF 2002

I,  Joseph  Flynn,  certify  that:

1.  I  have  reviewed this Annual Report on Form 10-KSB of PeopleView, Inc. (the
"Registrant");

2.  Based  on  my  knowledge,  this  Annual  report  does not contain any untrue
statement  of a material fact or omit to state a material fact necessary to make
the  statements  made, in light of the circumstances under which such statements
were  made,  not  misleading  with  respect to the period covered by this Annual
Report;

3.  Based  on  my  knowledge,  the  financial  statements,  and  other financial
information  included  in  this  annual  report,  fairly present in all material
respects  the  financial  condition, results of operations and cash flows of the
registrant  as  of,  and  for,  the  periods  presented  in  this Annual Report;

4.  PeopleViews' other certifying officer and I are responsible for establishing
and  maintaining  disclosure controls and procedures (as defined in Exchange Act
Rules  13a-14)  for  the  registrant  and  have:
a)     designed  such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is  made  known  to  me by others within those entities, particularly during the
period  in  which  this  annual  report  is  being  prepared;
b)     evaluated  the  effectiveness of the registrant's disclosure controls and
procedures  as  of a date within 90 days prior to the filing date of this Annual
Report  (the  "Evaluation  Date");  and
c)     presented in this Annual Report my conclusions about the effectiveness of
the  disclosure  controls  and  procedures  based  on  my  evaluation  as of the
Evaluation  Date;

5.  I  have  disclosed,  based on my most recent evaluation, to the registrant's
auditors  and the audit committee of registrant's board of directors (or persons
performing  the  equivalent  functions):
a)     all  significant  deficiencies  in  the  design  or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and  have  identified for the
registrant's  auditors  any  material  weaknesses  in  internal  controls;  and
b)     any  fraud,  whether  or  not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6. I have indicated in this annual report whether there were significant changes
in  internal  controls  or  in  other  factors  that  could significantly affect
internal controls subsequent to the date of my most recent evaluation, including
any  corrective  actions  with  regard  to significant deficiencies and material
weaknesses.

Dated:  April  14,  2004


 /s/  Joseph  Flynn
-------------------
Joseph  Flynn,
Chief  Executive  Officer
(Principal  Executive  Officer)
Table of Contents

Exhibit 4.17

[THE COCA-COLA COMPANY LETTERHEAD]

June 2, 2008

Coca-Cola FEMSA de Costa Rica, S.A. 
República de Costa Rica

Dear Sirs:

In regards to the Bottler Agreement in force and effect since October 1, 2002 (the Agreement) entered into between you and The Coca-Cola Company (the Company), we inform you that a new bottler agreement is in the final stages
  of discussion and approval among the parties, which we estimate will be executed towards the middle of September 2008, hereby the Agreement is temporarily extended from March 31, 2008 until:

September 30, 2008

With the exception of said extension, all the terms and conditions of the Agreement will continue to be fully valid until the expiration of the additional term, and once the extension expires, the Bottler will no longer have the right to claim a
  tacit renewal of the aforementioned Agreement.



| |                          
| | -------------------------
| | Sincerely,               
| |                          
| | THE COCA-COLA COMPANY    
| |                          
| |                          
| | /s/                      
| |                          
| | Authorized Representative





|                                    | 
|----------------------------------- | 
|Accepted by:                        | 
|COCA-COLA FEMSA DE COSTA RICA, S.A. | 
|                                    | 
|                                    | 
|                                    | 
|/s/                                 | 
|                                    | 
|Authorized Representative           |
32.2 SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
 PURSUANT TO 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In connection with the Quarterly Report of Commonwealth Income & Growth Fund IV, (the “Company”) on Form 10-Q for the quarter ending March 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kimberly A. Springsteen-Abbott, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
 
 (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
 
 /s/Kimberly A. Springsteen-AbbottKimberly A. Springsteen-AbbottPrincipal Financial OfficerMay 17, 2010
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4880 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
                                H. R. 4880

  To revise the boundaries of certain John H. Chafee Coastal Barrier 
                  Resources System units in Delaware.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 25, 2018

 Ms. Blunt Rochester introduced the following bill; which was referred 
                 to the Committee on Natural Resources

_______________________________________________________________________

                                 A BILL

 
  To revise the boundaries of certain John H. Chafee Coastal Barrier 
                  Resources System units in Delaware.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REPLACEMENT OF JOHN H. CHAFEE COASTAL BARRIER RESOURCES 
              SYSTEM MAP.

    (a) In General.--The map subtitled ``Delaware Seashore Unit DE-07P, 
North Bethany Beach Unit H01'' and dated December 6, 2013, that is 
included in the set of maps entitled ``Coastal Barrier Resources 
System'' referred to in section 4(a) of the Coastal Barrier Resources 
Act (16 U.S.C. 3503(a)) and relating to certain John H. Chafee Coastal 
Barrier Resources System units in the State of Delaware, is replaced by 
the map entitled ``Delaware Seashore Unit DE-07/DE-07P, North Bethany 
Beach Unit H01'' and dated March 18, 2016.
    (b) Availability.--The Secretary of the Interior shall keep the 
replacement map referred to in subsection (a) on file and available for 
inspection in accordance with section 4(b) of the Coastal Barrier 
Resources Act (16 U.S.C. 3503(b)).
                                 <all>
```
Exhibit 23.2







CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (Nos. 333-23687, 333-33643, 333-33795, 333-108908 and 333-112144) and on Forms S-8 (Nos. 033-52375, 333-18215, 333-70681, 333-74707 and 333-115468) of Bedford Property Investors, Inc. of our report dated March 9, 2005 relating to the financial statements, financial statement schedule, managements assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.





/s/ PricewaterhouseCoopers LLP

San Francisco, California

March 11, 2005
Michigan Supreme Court

Lansing, Michigan

Bridget M. McCormack, Chief Justice

Brian K. Zahra

David F. Viviano

Richard H. Bernstein

Elizabeth T. Clement

Megan K. Cavanagh

Elizabeth M. Welch, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 February 5, 2021

Order 

Clerk

February 5, 2021

161092(51)

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee,

SC: 161092

v COA: 344703

Wayne CC: 17-010362-FC

DEANDRE TERREL AUSTIN, Defendant-Appellant. 

______________________________________/

On order of the Chief Justice, the motion of defendant-appellant to extend the time 

for filing his supplemental brief is GRANTED. The supplemental brief will be accepted 

as timely filed if submitted on or before March 8, 2021.
EXHIBIT 32
 WRITTEN STATEMENT OF CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER
  Dated: May 13, 2009/s/ D. SCOTT MERCERD. Scott MercerChairman of the Board and Chief Executive Officer/s/ JEAN HUJean HuChief Financial Officer and Senior Vice President,
Business Development
<PAGE>
 
                                   EXHIBIT 23
<PAGE>
 
                          CONSENT OF ERNST & YOUNG LLP
                              INDEPENDENT AUDITORS
                                        

     We consent to the incorporation by reference in the Registration Statements
on Form S-8 (Numbers 33-85216, 33-81270, 333-17755, 33-78820, 33-95584, 333-
06221, 333-23757, 333-49133 and 333-58327) pertaining to the Friedman's Inc.
1993 Stock Option Plan, Friedman's Inc. 1994 Stock Option Plan for Outside
Directors, Friedman's Inc. Amended and Restated 1994 Stock Option Plan for
Outside Directors, Friedman's Inc. 1994 Qualified Employee Stock Purchase Plan,
Friedman's Inc. 1994 Stock Option Plan, Friedman's Inc. 1995 Stock Option Plan,
Friedman's Inc. 1996 Stock Option Plan, Friedman's Inc. 1997 Stock Option Plan
and Friedman's Inc. Retirement Savings Plan, of our report dated November 18,
1998 with respect to the consolidated financial statements and schedule of
Friedman's Inc. included in the Annual Report on Form 10-K for the year ended
September 30, 1998.


                                        /s/ Ernst & Young LLP

Atlanta, Georgia
December 18, 1998
# C_2009032EN.01004001.xml

| 7.2.2009 | EN | Official Journal of the European Union | C 32/40 |
| --- | --- | --- | --- |

7.2.2009

EN

Official Journal of the European Union

C 32/40

---

Action brought on 18 November 2008 — Wessang v OHIM — Greinwald (star foods)

(Case T-492/08)

(2009/C 32/77)

Language in which the application was lodged: French

Parties

Applicant: Nicolas Wessang (Zimmerbach, France) (represented by: A. Grolée, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal: Greinwald GmbH (Kempten, Germany)

Other party to the proceedings before the Board of Appeal:

Form of order sought

| — | Annul the decision of the Board of Appeal of OHIM of 17 September 2008; |
| --- | --- |

—

Annul the decision of the Board of Appeal of OHIM of 17 September 2008;

| — | Uphold the opposition filed by Mr Nicolas WESSANG of 26 September 2005 against the application for registration of the mark STAR FOODS + device No 004105615; |
| --- | --- |

—

Uphold the opposition filed by Mr Nicolas WESSANG of 26 September 2005 against the application for registration of the mark STAR FOODS + device No 004105615;

| — | Reject that application for registration No 004105615 in its entirety; |
| --- | --- |

—

Reject that application for registration No 004105615 in its entirety;

| — | Order the company Greinwald GmbH to pay the whole of the costs incurred by Mr Nicolas WESSANG in the opposition proceedings, the appeal proceedings and the present proceedings. |
| --- | --- |

—

Order the company Greinwald GmbH to pay the whole of the costs incurred by Mr Nicolas WESSANG in the opposition proceedings, the appeal proceedings and the present proceedings.

Pleas in law and main arguments

Applicant for a Community trade mark: Greinwald GmbH

Applicant for a Community trade mark:

Community trade mark concerned: Figurative mark ‘star foods’ for goods in Classes 29, 30 and 32 — application No 4 105 615

Community trade mark concerned:

Proprietor of the mark or sign cited in the opposition proceedings: Nicolas Wessang

Proprietor of the mark or sign cited in the opposition proceedings:

Mark or sign cited in opposition: Community figurative and word marks ‘STAR SNACKS’ for goods in Classes 29, 30 and 31

Mark or sign cited in opposition:

Decision of the Opposition Division: The opposition is upheld

Decision of the Opposition Division:

Decision of the Board of Appeal: Annulment of the decision of the Opposition Division and rejection of the opposition

Decision of the Board of Appeal:

Pleas in law: According to the applicant, there is a likelihood of confusion between the two marks at issue, to the extent that they are extremely similar both visually and phonetically or conceptually and refer to similar or even identical goods.

Pleas in law:

---
```

[Congressional Record Volume 158, Number 128 (Thursday, September 20, 2012)]
[Senate]
[Page S6558]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                              NOMINATIONS

  Executive nominations received by the Senate:

                             THE JUDICIARY

       KETANJI BROWN JACKSON, OF MARYLAND, TO BE UNITED STATES 
     DISTRICT JUDGE FOR THE DISTRICT OF COLUMBIA, VICE HENRY 
     HAROLD KENNEDY, RETIRED.
       NELSON STEPHEN ROMAN, OF NEW YORK, TO BE UNITED STATES 
     DISTRICT JUDGE FOR THE SOUTHERN DISTRICT OF NEW YORK, VICE 
     RICHARD M. BERMAN, RETIRED.
       ROBERT D. OKUN, OF THE DISTRICT OF COLUMBIA, TO BE AN 
     ASSOCIATE JUDGE OF THE SUPERIOR COURT OF THE DISTRICT OF 
     COLUMBIA FOR THE TERM OF FIFTEEN YEARS, VICE LINDA KAY DAVIS, 
     RETIRED.
```
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
THIS RESTATED FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION
EXTRACTED FROM THE COMPANY'S CONSOLIDATED BALANCE SHEET AT SEPTEMBER 27, 1997
AND FROM THE CONSOLIDATED STATEMENT OF OPERATIONS FOR THE NINE MONTHS ENDED
SEPTEMBER 27, 1997 CONTAINED IN THE COMPANY'S QUARTERLY REPORT ON FORM 10-Q FOR
THE NINE MONTHS ENDED SEPTEMBER 27, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH QUARTERLY REPORT ON FORM 10-Q.
</LEGEND>
<CIK> 0000910721
<NAME> DM MANAGEMENT COMPANY
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-27-1997
<PERIOD-START>                             DEC-29-1996
<PERIOD-END>                               SEP-27-1997
<EXCHANGE-RATE>                                      1
<CASH>                                             582
<SECURITIES>                                     3,888
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     18,498
<CURRENT-ASSETS>                                33,883
<PP&E>                                           7,930
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  48,839
<CURRENT-LIABILITIES>                           18,531
<BONDS>                                          6,150
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            47
<OTHER-SE>                                      24,111
<TOTAL-LIABILITY-AND-EQUITY>                    48,839
<SALES>                                         89,077
<TOTAL-REVENUES>                                89,077
<CGS>                                           39,399
<TOTAL-COSTS>                                   55,947
<OTHER-EXPENSES>                                29,049
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  86
<INCOME-PRETAX>                                  3,995
<INCOME-TAX>                                     1,558
<INCOME-CONTINUING>                              2,437
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,437
<EPS-PRIMARY>                                     0.53
<EPS-DILUTED>                                     0.48
        

</TABLE>
2014 Decisions

Opinions of the United

States Court of Appeals

for the Third Circuit

1-17-2014

USA v. Bruce Costa, Jr.

Precedential or Non-Precedential: Non-Precedential

Docket 13-1218

Follow this and additional works at: http://digitalcommons.law.villanova.edu/thirdcircuit_2014

This decision is brought to you for free and open access by the Opinions of the United States Court of Appeals for the Third Circuit at Villanova

University School of Law Digital Repository. It has been accepted for inclusion in 2014 Decisions by an authorized administrator of Villanova

University School of Law Digital Repository. For more information, please contact Benjamin.Carlson@law.villanova.edu.

Recommended Citation

"USA v. Bruce Costa, Jr." (2014). 2014 Decisions. Paper 84.

http://digitalcommons.law.villanova.edu/thirdcircuit_2014/84
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT

January 16, 2014

No. 13-1218

USA

v.

BRUCE E. COSTA, JR.

(D. Del. No. 1-10-cr-00047-001)

Present: JORDAN, VANASKIE and VAN ANTWERPEN, Circuit Judges

Unopposed Motion by Appellant to Amend Opinion filed January 2, 2014.

Respectfully,

Clerk/arl

_________________________________ORDER________________________________

The foregoing Motion is granted. The January 2, 2014 opinion is vacated. A revised 

opinion and judgment will be entered.

By the Court,

s/ Kent A. Jordan 

Circuit Judge

Dated: January 17, 2014

ARL/cc: SAW; LCW; MDC; JMV
Exhibit 99.2
 (VALEANT LOGO)
 
 Contact:
 VALEANT ANNOUNCES SUCCESFUL COMPLETION OF RETIGABINE PHASE III
EPILEPSY PROGRAM VALIDATING NOVEL MECHANISM OF ACTION
 
    
    RESTORE 2 shows efficacy in both 600 mg and 900 mg doses, building upon
prior positive Phase III results with 1200 mg dose
    
    Retigabine is a potentially significant advance for treatment of epilepsy
    
    Valeant plans to submit NDA & MAA before end of 2008
 Conference Call scheduled for today at 1:00 p.m. EDT (10:00 a.m. PDT)




---



##### 



SUMMARY EFFICACY DATA
 Placebo
    
    
    RTG 600 mg
    
    
    RTG 900 mgMedian reduction in
    
    
    15.9%
    
    
    
    27.9%
    
    
    
    39.9%28-day total partial
    
    
    n=179
    
    
    
    n=181
    
    
    
    n=178seizure frequency*
(ITT)Median reduction in
    
    
    17.4%
    
    
    
    35.3%
    
    
    
    44.3%28-day total partial
    
    
    n=164
    
    
    
    n=158
    
    
    
    n=149seizure frequency
during Maintenance
PhaseResponder Rate (ITT)
    
    
    17.3%
    
    
    
    31.5%
    
    
    
    39.3%n=179
    
    
    
    n=181
    
    
    
    n=178Responder Rate
    
    
    18.9%
    
    
    
    38.6%
    
    
    
    47.0%during Maintenance
    
    
    n=164
    
    
    
    n=158
    
    
    
    n=149Phase**
 
 ITT
    
    population defined as all subjects taking at least 1 dose of study medication*
    
    FDA endpoint**
    
    Endpoint per EU Committee for Human Medicinal Products (CHMP)
    
    p <0.01 compared to placebo
    
    Responder Rate defined as
3 50% reduction in 28-day total partial seizure frequency  RESTORE 2 Trial Design
 R E S T O E




---



##### 



About Epilepsy
   About Potassium Channel Openers
  About Retigabine Program




---



##### 



About Valeant
 www.valeant.com
 Conference Call and Webcast Information:
  FORWARD-LOOKING STATEMENTS
EX-10.55






ALLONGE TO MORTGAGE NOTE

(Sea Breeze)




This Allonge to Mortgage Note (“Allonge”) is made as of this 10th day of January,
2012, by and G&E HC REIT II Mobile SNF, LLC, a Delaware limited liability company (“Borrower”) to
Capital Funding, LLC (“Lender”).



WHEREAS, Ivan Associates, L.P., a Georgia limited partnership (“Original Borrower”) signed a
Mortgage Note dated July 1, 2010 (the “Note”) in the original principal amount of $5,168,000.00;
and



WHEREAS, pursuant to an Assumption, Modification and Release Agreement dated of even date
herewith (the “Assumption Agreement”), Borrower has assumed the Note from the Original Borrower and
the Borrower desires to enter into this Allonge to reflect such assumption.



NOW, THEREFORE, for good and valuable consideration and intending to be legally bound hereby,
the parties hereto agree as follows:



(1) The said Note is hereby amended to substitute the Borrower for the Original Borrower under
the Note. Said Borrower shall assume all liability under the Note arising as of the date hereof
and the Original Borrower shall be released from liability under the Note as provided in the
Assumption Agreement.



(2) Except as expressly amended hereby, the Note shall remain unchanged and in full force and
effect.



[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]







1






IN WITNESS WHEREOF, this Allonge to Mortgage Note is made as of the day and year first written
above.




G&E HC REIT II Mobile SNF, LLC, a Delaware limited
liability company




By: /s/ Danny Prosky

Name: Danny Prosky

Title: Authorized Signatory





2
<PAGE>   1

                                                                    EXHIBIT 23.1


               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS



The Board of Directors and Stockholders
Epoch Pharmaceuticals, Inc.:


We consent to incorporation by reference in the registration statement (No.
33-66742) on Form S-3 of Epoch Pharmaceuticals, Inc. of our report dated
February 10, 1999, relating to the balance sheet of Epoch Pharmaceuticals, Inc.
as of December 31, 1998, and the related statements of operations, stockholders'
equity (deficit) and cash flows for each of the years in the two-year period
ended December 31, 1998, which report appears in the December 31, 1998 annual
report on form 10-KSB of Epoch Pharmaceuticals, Inc.

Our report dated February 10, 1999 contains an explanatory paragraph which
states that the Company has suffered reoccurring losses from operations and has
a net capital deficiency, which raises substantial doubt about its ability to
continue as a going concern. The financial statements do not include any
adjustments that might result from the outcome of that uncertainty.


                                                     KPMG LLP


Seattle, Washington
April 14, 1999
Exhibit
32.2





WRITTEN
STATEMENT OF THE CHIEF FINANCIAL OFFICER


PURSUANT
TO 18 U.S.C. 1350





Solely
for the purposes of complying with 18 U.S.C. 1350, I, the undersigned Chief
Financial Officer of Liquidmetal Technologies, Inc. (the “Company”), hereby
certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the
Company for the quarter ended September 30, 2010 (the “Report”) fully complies
with the requirements of Section 13(a) of the Securities Exchange Act of 1934
and that the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.





/s/  Tony
ChungTony
      Chung, Chief Financial OfficerNovember
      4, 2010